I think the one thing that Tran took with him was his name, as lead investigator which was going to be written/was written everywhere on the filing-this may have been the reason for re-filing or postponing-finding another lead. I was made aware that they feel though there is enough experience on board they still might have brought in someone.
I didnt have the audio feed. Apparently they didnt update the slide--which should have been done. Since they continue to feature the ADHD plan so prominently, apparently it has not been derailed, so my assumption that something would have to be 'seriously wrong' is incorrect. What the final details being wrapped up may be is a mystery to me. It certainly is preferable to have them wrapped up before filing--than to have the FDA start resetting the clock ad infinitum as they examine the IND and identify flaws.
News 
Market Data 
Discover 
AI
